Rafferty Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$503K Sell
292,453
-129,076
-31% -$222K ﹤0.01% 885
2025
Q1
$1.4M Sell
421,529
-132,612
-24% -$442K 0.01% 669
2024
Q4
$4.1M Sell
554,141
-98,825
-15% -$731K 0.01% 454
2024
Q3
$6.13M Sell
652,966
-71,213
-10% -$669K 0.02% 371
2024
Q2
$5.81M Buy
724,179
+140,068
+24% +$1.12M 0.02% 390
2024
Q1
$8.66M Sell
584,111
-663,404
-53% -$9.83M 0.03% 321
2023
Q4
$10.1M Sell
1,247,515
-248,655
-17% -$2.02M 0.04% 274
2023
Q3
$6.81M Buy
1,496,170
+443,249
+42% +$2.02M 0.04% 330
2023
Q2
$7.41M Sell
1,052,921
-42,518
-4% -$299K 0.04% 315
2023
Q1
$6.69M Sell
1,095,439
-70,259
-6% -$429K 0.05% 308
2022
Q4
$7.45M Buy
1,165,698
+547,013
+88% +$3.5M 0.06% 283
2022
Q3
$5.93M Buy
618,685
+158,605
+34% +$1.52M 0.06% 296
2022
Q2
$5.08M Buy
460,080
+54,372
+13% +$600K 0.05% 273
2022
Q1
$6.76M Buy
405,708
+120,202
+42% +$2M 0.04% 283
2021
Q4
$5.45M Buy
285,506
+148,649
+109% +$2.84M 0.03% 356
2021
Q3
$3.38M Buy
136,857
+25,622
+23% +$632K 0.02% 415
2021
Q2
$2.89M Buy
111,235
+15,186
+16% +$395K 0.02% 510
2021
Q1
$3.04M Buy
96,049
+77,386
+415% +$2.45M 0.02% 485
2020
Q4
$866K Sell
18,663
-43,929
-70% -$2.04M 0.01% 542
2020
Q3
$2.06M Buy
62,592
+30,227
+93% +$995K 0.02% 408
2020
Q2
$888K Buy
32,365
+20,237
+167% +$555K 0.01% 581
2020
Q1
$363K Sell
12,128
-90,862
-88% -$2.72M 0.02% 388
2019
Q4
$2.85M Sell
102,990
-138,670
-57% -$3.84M 0.04% 233
2019
Q3
$4.4M Buy
241,660
+145,274
+151% +$2.64M 0.07% 169
2019
Q2
$2.36M Sell
96,386
-52,051
-35% -$1.28M 0.04% 327
2019
Q1
$1.41M Buy
+148,437
New +$1.41M 0.02% 481